Stockreport

Seelos on go to launch pivotal study of trehalose in Sanfilippo; shares up 7% [Seeking Alpha]

Seelos Therapeutics, Inc.  (SEEL) 
Last seelos therapeutics, inc. earnings: 5/21 05:12 pm Check Earnings Report
PDF The FDA has signed off on Seelos Therapeutics' ( SEEL ) IND for a Phase 2b/3 clinical trial evaluating SLS-005 (trehalose) in patients with mucopolysacchar [Read more]